United States Lung Stents Market valuation $173.99 million by 2033 - Exclusive Report by DatamIntelligence

Leander, Texas, United States - Nov. 17. 2025 "Global Lung Stents Market reached US$ 175.57 million in 2024 and is expected to reach US$ 579.98 million by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/lung-stents-market?sp

United States: Recent Industry Developments

✅ In October 2025, Medtronic launched its next-generation lung stent with improved flexibility and drug-eluting capabilities for airway obstruction patients. The device enhances airway patency and reduces restenosis risk. It targets patients with chronic respiratory conditions and complex pulmonary lesions.

✅ In September 2025, Boston Scientific expanded its airway stent portfolio with a biodegradable lung stent option for temporary airway support. The stent gradually dissolves after healing, reducing the need for removal procedures. It supports minimally invasive pulmonary interventions.

✅ In August 2025, Gore Medical introduced the GORE® LYRATM bronchial stent in the U.S., designed for malignant and benign airway obstructions. The stent provides conformable support and easy deployment. It improves outcomes for patients requiring long-term airway management.

✅ In July 2025, Pulmonx developed a personalized 3D-printed lung stent platform for complex airway anatomies. The stents are tailored to individual patient needs using imaging-guided design. This innovation enhances precision and effectiveness in interventional pulmonology.

Japan: Recent Industry Developments

✅ In October 2025, Fuji Systems introduced a drug-eluting airway stent for malignant lung obstruction, approved by Japan's PMDA. The device reduces inflammation and restenosis in patients. It strengthens Japan's interventional pulmonology toolkit.

✅ In September 2025, Olympus Corporation launched a biodegradable bronchial stent for temporary airway support in Japan. The stent dissolves naturally after healing, minimizing follow-up interventions. It targets patients with benign airway conditions.

✅ In August 2025, Terumo Japan deployed 3D-printed customizable lung stents for patients with complex airway anatomies. The platform integrates CT imaging for precise stent design. It improves treatment outcomes and procedural accuracy.

✅ In July 2025, Nipro Corporation introduced a next-generation self-expanding lung stent for malignant airway obstructions. The device offers improved radial strength and flexibility. It enhances safety and efficacy in interventional pulmonary procedures.

Lung Stents Market: Drivers

The global lung stents market is gaining momentum as the prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, and tracheobronchial stenosis continues to rise. Increasing demand for minimally invasive procedures and advancements in interventional pulmonology are driving the adoption of lung stents for airway management. Technological innovations have led to the development of bioresorbable and drug-eluting stents that enhance patient safety and treatment outcomes. The growing geriatric population, which is more susceptible to respiratory disorders, further contributes to market growth. Additionally, the increasing availability of advanced healthcare infrastructure in emerging economies is expanding access to lung stent procedures.

Rising awareness of early disease diagnosis and the availability of novel stent materials such as silicone, metal, and hybrid composites are supporting product innovation. Healthcare providers are increasingly adopting endoscopic techniques for stent placement due to reduced recovery times and improved patient comfort. Strategic collaborations between medical device manufacturers and research institutions are fueling clinical trials and regulatory approvals. Moreover, the rising healthcare expenditure and focus on improving quality of life for patients with airway obstructions are fostering market expansion. With continued technological progress and growing global demand for minimally invasive respiratory treatments, the lung stents market is set to witness steady growth in the coming years.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lung-stents-market?sp

Lung Stents Market: Major Players

Boston Scientific Corporation, Cook Medical, ELLA-CS, s.r.o, Merit Medical Systems, Inc., Novatech SA, Micro-Tech (Nanjing) Co., Ltd., S&G Biotech Inc., Medorah Meditek Pvt. Ltd, Mitrai Industries and E. Benson Hood Laboratories, Inc.

Segment Covered in the Lung Stents Market:

By Product Type:
Tracheal stents dominate the market owing to their vital role in maintaining airway patency for patients with tracheal obstruction. Bronchial stents follow closely, primarily used for treating malignant and benign bronchial strictures. Other stent types, including bioresorbable and custom-designed variants, are gradually gaining traction due to their improved adaptability, biocompatibility, and reduced post-procedural complications.

By Material:
Metal stents lead the segment, favored for their superior durability and structural integrity, making them suitable for long-term airway support. Silicone stents, however, are preferred in cases of benign airway obstruction because they are removable, flexible, and cause minimal tissue irritation. Hybrid stents, combining the advantages of metal and silicone, are emerging as a preferred choice for complex airway conditions, offering both flexibility and stability.

By End-User:
Hospitals hold the largest share of the market, attributed to the availability of skilled pulmonologists, advanced bronchoscopy units, and comprehensive post-procedure care. Ambulatory surgical centers are witnessing rapid growth due to the increasing adoption of minimally invasive and outpatient procedures that reduce patient recovery time. Specialty clinics are also gaining prominence as they cater to chronic respiratory patients requiring long-term monitoring and stent maintenance.

Regional Analysis:

North America, with an estimated 38% market share, leads the global lung stents market, driven by a high prevalence of COPD, lung cancer, and asthma-related complications. The U.S. dominates the regional landscape, supported by advanced healthcare infrastructure, strong adoption of interventional pulmonology, and favorable reimbursement systems.

Europe holds around 27% of the global share, supported by a mature healthcare system and the presence of major medical device manufacturers. Countries such as Germany, the U.K., and France are at the forefront of adopting minimally invasive bronchoscopic procedures and new stent technologies.

Asia Pacific accounts for approximately 22% of the market and represents the fastest-growing region, fueled by increasing cases of respiratory diseases linked to pollution and smoking. China, Japan, and India are key contributors, with growing awareness and investments in respiratory healthcare and local manufacturing capabilities.

South America, holding roughly 7% of the global market, is driven by improving healthcare infrastructure in countries like Brazil and Argentina. Government initiatives and awareness campaigns are enhancing access to interventional respiratory therapies across the region.

The Middle East & Africa region captures nearly 6% of the total share, witnessing gradual growth due to expanding healthcare digitalization and rising investments in advanced pulmonary care, particularly across GCC nations. Increasing collaborations with international healthcare providers and medical technology firms are further supporting market development.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=lung-stents-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.